TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Adlai Nortye to Participate in Upcoming Investor Conferences

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Adlai Nortye Ltd.
Adlai Nortye to Participate in Upcoming Investor Conferences

Adlai Nortye, a clinical-stage biotechnology company, will participate in two healthcare investor conferences in late 2025 and early 2026, presenting its innovative cancer therapy pipeline.

Insights
ANL   positive

Company is showcasing its innovative cancer therapy pipeline, participating in prominent investor conferences, and highlighting potential breakthrough treatments like AN8025, AN4005, AN9025, and AN4035